Physician profile
Peter Pitonak
NPI 1225128259
$1,949.08
in general payments reported to CMS, 2019-2025
19 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $483 · 2021: $279 · 2022: $305 · 2023: $454 · 2024: $286 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $881.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $341.11 | 2021-2025 | Amvuttra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $266.24 | 2022-2025 | Lifevest |
| Pfizer INC. | $213.78 | 2019-2024 | |
| Heartflow, INC. | $178.18 | 2021-2025 | Ffrct |
| Abbott Laboratories | $131.09 | 2023 | Mitraclip |
| E.R. Squibb & Sons, L.L.C. | $122.16 | 2022-2024 | Camzyos |
| Novo Nordisk INC | $120.85 | 2022 | |
| Amgen INC. | $118.36 | 2019-2024 | Repatha |
| Medtronic Vascular, INC. | $112.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $75.42 | 2019-2024 | |
| Irhythm Technologies, INC. | $46.91 | 2019-2021 | |
| Terumo Medical Corporation | $44.61 | 2023 | Glidesheath Slender, Tr Band |
| Sanofi-Aventis U.S. LLC | $37.73 | 2019-2024 | |
| Boston Scientific Corporation | $33.36 | 2023 | Watchman Access System |
| Janssen Pharmaceuticals, INC | $29.52 | 2019-2024 | Xarelto |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $28.76 | 2022-2024 | Onyx Frontier |
| Abiomed | $19.33 | 2019 | |
| Cvrx, INC. | $18.70 | 2024 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $10.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Pitonak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.